Core Viewpoint - Monteverde & Associates PC is investigating the proposed sale of 89bio, Inc. to Roche Holdings, Inc., focusing on whether the deal is fair for shareholders [1]. Company Overview - Monteverde & Associates PC is a national class action securities firm based in the Empire State Building, New York City, recognized for recovering millions for shareholders [2][3]. - The firm has a successful track record in trial and appellate courts, including the U.S. Supreme Court [2]. Transaction Details - Under the proposed transaction, 89bio shareholders will receive $14.50 per share in cash at closing, along with a non-tradeable contingent value right for potential additional payments of up to $6.00 per share based on specified milestones [1].
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)